This site is intended for healthcare professionals only
LoginRegister

Cardiology-CTVS Dialogues

Dapagliflozin 5 mg daily attenuates CV events among diabetes patients with chronic HF

Dapagliflozin 5 mg daily attenuates CV events among diabetes patients with chronic HF

The DAPPER study was conducted with the National Cardiovascular Center as the principal investigator, with 294 patients participating from 18...
View All

Latest News and Guidelines

Clinical smart watch finds success at identifying atrial fibrillation

Clinical smart watch finds success at identifying atrial fibrillation

Green coffee may help improve lipid profile and inflammation in diabetes patients: Study

Green coffee may help improve lipid profile and inflammation in diabetes patients: Study

Aspirin-free antithrombotic regimen safe and may Benefit Patients with LVAD

Aspirin-free antithrombotic regimen safe and may Benefit Patients with LVAD

Gujarat sees 1,052 heart attack deaths in 6 months, 80 pc of deceased in 11-25 age group: Minister

Gujarat sees 1,052 heart attack deaths in 6 months, 80 pc of deceased in 11-25 age group: Minister

Colchicine Flops in Reducing AF or Myocardial Injury Following Non-Cardiac Surgery

Colchicine Flops in Reducing AF or Myocardial Injury Following Non-Cardiac Surgery

First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM Patients Uncontrolled on Existing Therapy

First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM...

View All
X